\-\ Texto\\:\\ \ \(0\)\
\-\ numerous\\,\\ scattered\\,\\ small\\ masses\ \(0\)\
\-\ lung\\ metastasis\ \(4\)\
\-\ malignancy\\ \\(primary\\,\\ metastatic\\)\ \(0\)\
\-\ inflammation\\/granulomatous\\ dz\ \(0\)\
\-\ benign\\ neoplasm\\ \ \(3\)\
\-\ congenital\\ abn\ \(10\)\
\-\ 57yo\\ f\\ with\\ 1\\ mo\\ cough\\ presents\\ for\\ f\\/u\\ cxr\\.\\ cxr\\ 1\\ mo\\ ago\\ showed\\ interstitial\\ infiltrates\\ and\\ was\\ prescribed\\ abx\\.\\ \\ pmh\\ includes\\ colon\\ cancer\\ \\â\\€\\“\\ dx\\ 5y\\ ago\\ as\\ stage\\ 2\\ with\\ hepatic\\ metastases\\.\ \(0\)\
\-\ 15\\-20\\%\\ of\\ colon\\ cancer\\ patients\\ have\\ distant\\ metastases\\ at\\ time\\ of\\ presentation\\.\\ spread\\ is\\ via\\ lymphatic\\ or\\ hematogenous\\ dissemination\\,\\ or\\ continguous\\ spread\\.\\ liver\\ is\\ the\\ frequent\\ site\\ of\\ metastases\\,\\ as\\ the\\ portal\\ vein\\ is\\ the\\ primary\\ drainage\\ for\\ the\\ intestinal\\ tract\\;\\ other\\ common\\ sites\\ of\\ metastases\\ include\\ lungs\\,\\ lymph\\ nodes\\,\\ peritoneum\\;\\ more\\ rare\\ sites\\ include\\ brain\\ and\\ bone\\.\\ \\ 5yr\\ survival\\ 50\\-75\\%\\ dependent\\ upon\\ stage\\ at\\ presentation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ metastases\\:\\ 0\\.10737448382479366\ \(0\)\
\-\ mo\\:\\ 0\\.07914016499237282\ \(0\)\
\-\ sites\\:\\ 0\\.06847993147951215\ \(0\)\
\-\ inflammation\\/granulomatous\\:\\ 0\\.06481998841151837\ \(0\)\
\-\ abn\\:\\ 0\\.06481998841151837\ \(0\)\
\-\ 5y\\:\\ 0\\.06481998841151837\ \(0\)\
\-\ continguous\\:\\ 0\\.06481998841151837\ \(0\)\
\-\ spread\\:\\ 0\\.060785105835915856\ \(0\)\
\-\ 57yo\\:\\ 0\\.059723317966224654\ \(0\)\
\-\ 5yr\\:\\ 0\\.05674195687719403\ \(0\)\
\-\ 50\\-75\\:\\ 0\\.05674195687719403\ \(0\)\
\-\ stage\\:\\ 0\\.05360344748424039\ \(0\)\
\-\ cxr\\:\\ 0\\.05302988634007467\ \(0\)\
\-\ colon\\:\\ 0\\.04935195455621087\ \(0\)\
\-\ 15\\-20\\:\\ 0\\.04788921566891509\ \(0\)\
\-\ dissemination\\:\\ 0\\.04788921566891509\ \(0\)\
\-\ ago\\:\\ 0\\.046775423835253654\ \(0\)\
\-\ abx\\:\\ 0\\.0465486159866066\ \(0\)\
\-\ dz\\:\\ 0\\.04596006666547765\ \(0\)\
\-\ presentation\\:\\ 0\\.04328530344839827\ \(0\)\
\-\ peritoneum\\:\\ 0\\.04279254522362137\ \(0\)\
\-\ lymphatic\\:\\ 0\\.041764883882627564\ \(0\)\
\-\ cancer\\:\\ 0\\.041311253887717135\ \(0\)\
\-\ dx\\:\\ 0\\.04115178381689925\ \(0\)\
\-\ hematogenous\\:\\ 0\\.04058589380854536\ \(0\)\
\-\ f\\/u\\:\\ 0\\.039110373988970715\ \(0\)\
\-\ infiltrates\\:\\ 0\\.039110373988970715\ \(0\)\
\-\ primary\\:\\ 0\\.03722623916023083\ \(0\)\
\-\ prescribed\\:\\ 0\\.036995064632707624\ \(0\)\
\-\ distant\\:\\ 0\\.03666821343733385\ \(0\)\
\-\ intestinal\\:\\ 0\\.03562666551775277\ \(0\)\
\-\ include\\:\\ 0\\.035252257176915984\ \(0\)\
\-\ dependent\\:\\ 0\\.03390313091599656\ \(0\)\
\-\ survival\\:\\ 0\\.03368685234830322\ \(0\)\
\-\ portal\\:\\ 0\\.03307375228257491\ \(0\)\
\-\ f\\:\\ 0\\.03278536468585961\ \(0\)\
\-\ frequent\\:\\ 0\\.031413409130121285\ \(0\)\
\-\ pmh\\:\\ 0\\.031258604650725455\ \(0\)\
\-\ interstitial\\:\\ 0\\.03074109879218281\ \(0\)\
\-\ 1\\:\\ 0\\.02990185835234863\ \(0\)\
\-\ \\;\\:\\ 0\\.029785605712538143\ \(0\)\
\-\ \\%\\:\\ 0\\.029313544608029523\ \(0\)\
\-\ scattered\\:\\ 0\\.02925909203687515\ \(0\)\
\-\ nodes\\:\\ 0\\.028380083576214982\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.028277243561694834\ \(0\)\
\-\ numerous\\:\\ 0\\.02817582207542766\ \(0\)\
\-\ tract\\:\\ 0\\.027831474283632814\ \(0\)\
\-\ via\\:\\ 0\\.0269707643173018\ \(0\)\
\-\ site\\:\\ 0\\.026555233359483107\ \(0\)\
\-\ drainage\\:\\ 0\\.026277730947844528\ \(0\)\
\-\ hepatic\\:\\ 0\\.026238929057397147\ \(0\)\
\-\ upon\\:\\ 0\\.02568020915314772\ \(0\)\
\-\ lymph\\:\\ 0\\.025364282418710637\ \(0\)\
\-\ includes\\:\\ 0\\.02533000291057967\ \(0\)\
\-\ rare\\:\\ 0\\.024399633813774236\ \(0\)\
\-\ malignancy\\:\\ 0\\.024280071160305262\ \(0\)\
\-\ cough\\:\\ 0\\.02407540352064759\ \(0\)\
\-\ lungs\\:\\ 0\\.023792563220443205\ \(0\)\
\-\ metastasis\\:\\ 0\\.02352020092867593\ \(0\)\
\-\ congenital\\:\\ 0\\.022979110070900276\ \(0\)\
\-\ vein\\:\\ 0\\.022734803838339097\ \(0\)\
\-\ benign\\:\\ 0\\.021684193875244128\ \(0\)\
\-\ liver\\:\\ 0\\.021663393462005322\ \(0\)\
\-\ neoplasm\\:\\ 0\\.02139821011699947\ \(0\)\
\-\ masses\\:\\ 0\\.021239649985265348\ \(0\)\
\-\ showed\\:\\ 0\\.020601494617086005\ \(0\)\
\-\ as\\:\\ 0\\.019008492733737174\ \(0\)\
\-\ brain\\:\\ 0\\.01890699649487325\ \(0\)\
\-\ lung\\:\\ 0\\.018199699413520194\ \(0\)\
\-\ time\\:\\ 0\\.017747067847347888\ \(0\)\
\-\ at\\:\\ 0\\.01702592871811225\ \(0\)\
\-\ common\\:\\ 0\\.016443141264385272\ \(0\)\
\-\ patients\\:\\ 0\\.016261577936514896\ \(0\)\
\-\ metastatic\\:\\ 0\\.01581698090894184\ \(0\)\
\-\ more\\:\\ 0\\.01571453168611887\ \(0\)\
\-\ bone\\:\\ 0\\.015613490304851985\ \(0\)\
\-\ or\\:\\ 0\\.014728275720054522\ \(0\)\
\-\ other\\:\\ 0\\.014482636387518004\ \(0\)\
\-\ small\\:\\ 0\\.014474818267508224\ \(0\)\
\-\ \\,\\:\\ 0\\.013933606313389791\ \(0\)\
\-\ have\\:\\ 0\\.013606162340919792\ \(0\)\
\-\ 2\\:\\ 0\\.013530180121401074\ \(0\)\
\-\ presents\\:\\ 0\\.01283561981991122\ \(0\)\
\-\ is\\:\\ 0\\.012403473052604242\ \(0\)\
\-\ for\\:\\ 0\\.010722178656510517\ \(0\)\
\-\ was\\:\\ 0\\.007266746486865344\ \(0\)\
\-\ \\(\\:\\ 0\\.005311483281204857\ \(0\)\
\-\ \\)\\:\\ 0\\.005246600677303714\ \(0\)\
\-\ the\\:\\ 0\\.004066155432459582\ \(0\)\
\-\ of\\:\\ 0\\.0034265823764114242\ \(0\)\
\-\ and\\:\\ 0\\.0026471912607679182\ \(0\)\
\-\ \\.\\:\\ 0\\.00182718200501047\ \(0\)\
\-\ with\\:\\ 0\\.0017206496483807314\ \(0\)\
